• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

New line of attack: Immune system induces tumor dormancy

Tubingen, Germany - Researchers from Tubingen University have discovered that immune response can prevent tumor growth without killing tumor cells, according to ecancermedicalscience.

Tubingen, Germany

- Researchers from Tubingen University have discovered that immune response can prevent tumor growth without killing tumor cells, ecancermedicalscience reports.

Until now, scientists believed the immune system controlled tumor growth by killing cells, but researchers note immune responses can not only induce tumor dormancy, but also tumor growth, according to the study, published in Cancer Cell.

The study may lead to a new line of attack in the development of tumor vaccines.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.